BioWorld

Feb. 6, 2007

View Archived Issues

Regeneron's Antibody Platform Draws $120M In First License

Regeneron Pharmaceuticals Inc. unveiled the first licensing deal for what it believes is a revolutionary antibody discovery technology, a nonexclusive agreement with a guarantee of $80 million. (Bioworld Today) Read More

Deal-Making Competition Is Up; Winners Offer More Than Money

Read More

Researchers Share Strategies To Avoid Getting Lost In Translation

Read More

Bush Proposes To Up FDA Budget In Next Fiscal Year

Read More

Wyeth's Pair Of Hemophilia Deals Target Longer Action

Read More

Columbia Labs Plunges On Prochieve Phase III Failure

Read More

Enzo Brings In $15M For Various Clinical Programs

Read More

Other News To Note

Read More

Clinic Roundup

Read More